On Cancer

Filter by Tag

In the Lab

Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer

By Julie Grisham, MS, Science Writer/Editor | Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Tags: Cancer Biology; Cancer Care; Drug Discovery; Targeted Therapy; Prostate Cancer; Research

Honor

Physician-Scientist Charles Sawyers Awarded Breakthrough Prize in Life Sciences

By Media Staff | Wednesday, February 20, 2013

Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

Tags: Drug Discovery; Targeted Therapy; Treatment; Leukemias; Prostate Cancer; Research

Q&A

Developmental Biologist Lorenz Studer Comments on the 2012 Nobel Prize in Physiology or Medicine

By Eva Kiesler, PhD, Science Writer/Editor | Tuesday, December 11, 2012

Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.

Tags: Drug Discovery; Stem Cells; Research

In the Lab

Study Points the Way for Future Therapy to Revive a Damaged Immune System

By Eva Kiesler, PhD, Science Writer/Editor | Friday, April 6, 2012

A recent study holds promise for the development of a new type of drug to alleviate immune deficiency caused by cancer treatment, radiation injury, or certain diseases.

Tags: Blood & Marrow Stem Cell Transplantation; Drug Discovery; Immunology; Research

Pictured: Charles Sawyers & Howard Scher

In the News

New Medical Strides against Prostate Cancer

By Media Staff | Friday, February 3, 2012

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

Tags: Drug Discovery; Targeted Therapy; Prostate Cancer; Research

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens

Feature

Cell-Based Therapies Show Promise

By Julie Grisham, MS, Science Writer/Editor | Wednesday, December 28, 2011

Years of innovative research, technology development, and facility expansion at Memorial Sloan-Kettering have led to several new experimental treatments for people with cancer.

Tags: Cell Engineering; Cell Therapy; Immunotherapy; Drug Discovery; Experimental Therapeutics; Research

Feature

Out of the Lab and into the World: Scientific and Medical Inventions Benefit Cancer Patients

By Eva Kiesler, PhD, Science Writer/Editor | Thursday, December 15, 2011

Memorial Sloan-Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.

Tags: Cancer Care; Medical Technology; Drug Discovery; Experimental Therapeutics; Research

In the Lab

Findings Could Lead to the Development of a New Painkiller

By Eva Kiesler, PhD, Science Writer/Editor | Tuesday, December 13, 2011

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.

Tags: Drug Discovery; Pain Management; Molecular Pharmacology; Research

In the Lab

Researchers Show Therapy Could Improve Stem Cell Transplants

By Julie Grisham, MS, Science Writer/Editor | Monday, December 12, 2011

A Memorial Sloan-Kettering study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation safer and more effective.

Tags: Blood & Marrow Stem Cell Transplantation; Immunotherapy; Drug Discovery; Immunology; Research

Pictured: Breast tumor treated with paclitaxel

In the Lab

Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy

By Eva Kiesler, PhD, Science Writer/Editor | Friday, December 2, 2011

Recent findings by Memorial Sloan-Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

Tags: Cancer Biology; Cancer Genetics; Chemotherapy; Drug Discovery; Breast Cancer; Research

In the Lab

Researchers Discover Why New Melanoma Drug Stops Working

By Media Staff | Wednesday, November 23, 2011

Research led by investigators at Memorial Sloan-Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.

Tags: Drug Discovery; Targeted Therapy; Melanoma; Research